Foot blood flow in diabetic neuropathy
Blood flow in the foot of patients with diabetic neuropathy is substantially increased. Evidence for this high blood flow comes from several sources (Watkins & Edmonds 1983) , notably from Ward and his colleagues in Sheffield who first observed very abnormal Doppler sonogram patterns indicating a high diastolic blood flow and the presence of arteriovenous shunting (Scarpello et al. 1980) . This work has more recently been confirmed by direct plethysmographic measurements showing that foot blood flow in severe neuropathy is increased on average five times above normal (A G Archer, unpublished observations). Further direct evidence for arteriovenous shunting comes from Austrian studies describing the rapid passage to the veins of intraarterially injected radioactive-labelled albumin microspheres (Partsch 1977) . The raised venous Po2 reaching almost arterial levels (Boulton et al. 1981) , which is described by Ward et al. on page 1011 of this issue and shown to be a feature of the neuropathic foot, also indicates the presence of arteriovenous shunting.
The raised foot blood flow is responsible for the excessive warmth of the neuropathic foot, and also for the strikingly distended veins seen on the dorsum of the foot and the lower calfa new sign described by Ward et al. (p 1011). The leg may need to be raised to a considerable height before these distended veins collapse, a feature serving as further indirect evidence for arteriovenous shunting. Quantitation of abnormalities in diabetic neuropathy is difficult to obtain, making this simple bedside observation one both of great interest and of clinical value. Neuropathic oedema is another, albeit uncommon, feature which results from venous pooling caused by the vasodilatation and arteriovenous shunting of neuropathy. Its reversal by ephedrine (Edmonds et al. 1983 ) may at least in part be due to vasoconstriction, although renal mechanisms are probably active as well. Increased bone blood flow has also been demonstrated, and is probably responsible for demineralization of bone. This observation could provide the underlying mechanism for the development of Charcot joint changes when minimal trauma causes extensive and disfiguring bony destruction.
The cause of painful neuropathy of the feet is unknown. However, it is known that foot blood flow is increased in this type of neuropathy as it is in the commoner, non-painful sensory neuropathy. The suggestion by Ward et al. (p 1011) that remission of pain may be associated with decrease of blood flow is both of theoretical interest and could have important practical implications for treatment of this distressing condition.
Sympathetic nerve damage is the cause of the vasodilatation and high blood flow of diabetic neuropathy. R D Lawrence (1965) himself suggested many years ago that in diabetes 'the first attack is on non-medullated nerve fibres', and recently workers in Sweden have, by direct recording, shown that sympathetic failure is much commoner in diabetic neuropathy than in other neuropathies (Fagius 1982) . There is now a challenge to discover why this should occur in diabetes; and there is a hope that some patients might benefit if blood flow could be reduced. P J Watkins Diabetic Department King's College Hospital, London
